• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Relypsa, Inc. (RLYP)

    -NasdaqGS
    35.13 Down 0.64(1.79%) Jan 30, 4:00PM EST
    Add to Portfolio
    Prev Close:35.77
    Open:36.15
    Bid:32.50 x 400
    Ask:43.02 x 200
    1y Target Est:58.25
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:34.86 - 36.48
    52wk Range:17.60 - 52.74
    Volume:508,719
    Avg Vol (3m):429,911
    Market Cap:1.20B
    P/E (ttm):N/A
    EPS (ttm):-2.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    RLYPDown 1.79%1.20B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.38
    Quarterly EPS Est (Dec-14) :-0.74
    Mean Recommendation*:1.2
    PEG Ratio (5 yr expected):0.16

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Relypsa, Inc., a pharmaceutical company, focuses on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular, and metabolic diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback